An open-label phase 2a study investigating the efficacy and safety of a cathepsin S inhibitor in patients with moderate-to-severe psoriasis

Autor: Gadola, Stephan D., Färber, Petra, Posch, Maximilian G., Nagel, Sandra, Canducci, Filippo
Zdroj: In Journal of the American Academy of Dermatology November 2022 87(5):1089-1091
Databáze: ScienceDirect